BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Standard BioTools
LAB
$340M
| $3.23M | ﹤0.01% |
2,017,210
-4,148,506
| -67% | -$10.3M |
|
3827
Passage Bio
PASG
$14.4M
| $3.23M | ﹤0.01% |
68,417
-96,223
| -58% | -$4.49M |
|
3828
Pan American Silver
PAAS
$18.2B
| $3.22M | ﹤0.01% |
163,760
+41,472
| +34% | +$994K |
|
3829
PUT
Sabre
SABR
$731M
| $3.22M | ﹤0.01% |
552,000
+412,000
| +294% | +$3.44M |
|
|
BCYC
3830
Bicycle Therapeutics
BCYC
$269M
| $3.21M | ﹤0.01% |
191,106
+977
| +0.5% | +$20.6K |
|
|
ISPO
3831
DELISTED
Inspirato
ISPO
| $3.2M | ﹤0.01% |
+34,599
| New | +$3.99M |
|
3832
Bassett Furniture
BSET
$164M
| $3.2M | ﹤0.01% |
176,618
-456,926
| -72% | -$7.58M |
|
3833
Harrow
HROW
$1.45B
| $3.18M | ﹤0.01% |
436,678
+150
| +0% | +$1.01K |
|
3834
Shattuck Labs
STTK
$675M
| $3.18M | ﹤0.01% |
782,540
-1,399,247
| -64% | -$5.07M |
|
|
ENZ
3835
DELISTED
Enzo Biochem, Inc.
ENZ
| $3.17M | ﹤0.01% |
1,530,255
-10,336
| -0.7% | -$25.6K |
|
3836
Investar Holding Corp
ISTR
$415M
| $3.15M | ﹤0.01% |
144,031
+5,509
| +4% | +$113K |
|
3837
PennantPark Floating Rate Capital
PFLT
$689M
| $3.15M | ﹤0.01% |
274,262
+38,231
| +16% | +$474K |
|
3838
CION Investment
CION
$297M
| $3.15M | ﹤0.01% |
361,446
+49,155
| +16% | +$528K |
|
3839
Commercial Vehicle Group
CVGI
$154M
| $3.14M | ﹤0.01% |
537,986
-1,524,366
| -74% | -$10.4M |
|
3840
Fidus Investment
FDUS
$749M
| $3.14M | ﹤0.01% |
180,011
+24,495
| +16% | +$473K |
|
|
IBCE
3841
DELISTED
iShares iBonds Mar 2023 Term Corporate ex-Financials ETF
IBCE
| $3.13M | ﹤0.01% |
129,000
| – | – |
|
3842
Black Diamond Therapeutics
BDTX
$96.8M
| $3.13M | ﹤0.01% |
1,272,112
-1,057,052
| -45% | -$2.46M |
|
|
THRO
3843
iShares U.S. Thematic Rotation Active ETF
THRO
$6.55B
| $3.13M | ﹤0.01% |
160,000
| – | – |
|
3844
Cartesian Therapeutics
RNAC
$229M
| $3.11M | ﹤0.01% |
79,156
-146,339
| -65% | -$4.34M |
|
3845
Zymeworks
ZYME
$1.61B
| $3.1M | ﹤0.01% |
584,500
-388,951
| -40% | -$2.35M |
|
|
IVEG
3846
DELISTED
iShares Emergent Food and AgTech Multisector ETF
IVEG
| $3.09M | ﹤0.01% |
+150,000
| New | +$3.41M |
|
3847
Magnachip Semiconductor
MX
$119M
| $3.09M | ﹤0.01% |
212,433
+22,932
| +12% | +$394K |
|
|
RERE
3848
ATRenew
RERE
$939M
| $3.08M | ﹤0.01% |
1,029,965
+344,556
| +50% | +$1.01M |
|
3849
Apyx Medical
APYX
$173M
| $3.08M | ﹤0.01% |
524,729
-1,446,990
| -73% | -$7.42M |
|
|
SOND
3850
DELISTED
Sonder
SOND
| $3.06M | ﹤0.01% |
146,990
+95,030
| +183% | +$5.41M |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.